In this podcast episode, listen to Chris Parker, MD, and Bertrand Tombal, MD, PhD, as they discuss clinical implications of the latest data from ASCO 2021 on using radium-223, PSMA lutetium, and bone health approaches for the treatment and management of patients with metastatic castration-resistant prostate cancer.
Download this Podcast Pearls slideset based on the content from a CCO podcast covering recent new developments in the treatment of patients with metastatic castration-resistant prostate cancer.
In this podcast episode, listen to Karim Fizazi, MD, PhD, and Alicia K. Morgans, MD, MPH, as they discuss clinical implications of the latest data from ASCO 2021 on using androgen receptor–directed therapy for the treatment and management of patients with nonmetastatic castration-resistant prostate cancer.
Download this Podcast Pearls slideset based on the content from a CCO podcast covering the latest data on next-generation androgen receptor inhibitors for treatment of patients with nonmetastatic castration-resistant prostate cancer.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.